Licensing partner sought for development of prohibitin gene-based cancer Rx, Dx Feb. 22, 1999 No Comments
Protein farnesyltransferase inhibitors in development at Bristol-Myers Squibb Feb. 19, 1999 No Comments
Genzyme's oncology division in-licenses angiogenesis inhibitor for development Feb. 19, 1999 No Comments
Wistar Institute discovers mechanism of action of farnesyltransferase inhibitors Feb. 17, 1999 No Comments
First pivotal trial results reported for marimastat; BB to assess implications for development Feb. 16, 1999 No Comments